Cancer Trials New Zealand (CTNZ) is developing within a framework of a strong Australasian cooperative research
environment, and a large proportion of clinical cancer research in New Zealand is
currently focused around the six regional Cancer treatment centre research units.
CTNZ research
The developing CTNZ infrastructure is intended to facilitate a more rapid development
of new ideas from clinical investigators in New Zealand across all disciplines.
Currently, our main focus is on encouraging and supporting investigator initiated
phase I and randomised phase II oncology trials. As a result, a mechanism has been
developed to guide and actively support new concepts through the scientific and
ethical review stages, to identification of funding and then on to full implementation.
As the capacity of the trial centre increases, we will seek to encourage more early
phase / translational projects in collaboration with the New Zealand and international
biotechnology/pharmaceutical industry. CTNZ is also exploring links and usages of
rare tumour registries, national clinical databases, and pathology repositories.
If you have an idea for a clinical research project which you think CTNZ could
help with, please contac Director Michael Findlay or Project
Manager Stephanie
Pollard
at
cancertrialsnz@auckland.ac.nz.
Concept development templates and an outline of the CTNZ trial development process
can be downloaded here:
Concept development template(97.5KB DOC)
Time lines, individualised for each trial
All randomised clinical trials run by CTNZ are registered in a publicly accessible
database such as the
Australian New Zealand Clinical Trials Registry or the International
Standard Randomised Controlled Trial Number (ISRCTN) scheme.
